US Bancorp DE decreased its position in Nutrien Ltd. (NYSE:NTR – Get Rating) by 9.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 15,389 shares of the company’s stock after selling 1,549 shares during the period. US Bancorp DE’s holdings in Nutrien were worth $1,282,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Private Trust Co. NA bought a new position in Nutrien in the 2nd quarter worth about $29,000. Covestor Ltd bought a new position in Nutrien in the 1st quarter worth about $30,000. Zions Bancorporation N.A. grew its position in Nutrien by 55.2% in the 1st quarter. Zions Bancorporation N.A. now owns 301 shares of the company’s stock worth $31,000 after purchasing an additional 107 shares during the last quarter. CoreCap Advisors LLC bought a new position in Nutrien in the 2nd quarter worth about $32,000. Finally, Cambridge Trust Co. grew its position in Nutrien by 239.9% in the 2nd quarter. Cambridge Trust Co. now owns 503 shares of the company’s stock worth $40,000 after purchasing an additional 355 shares during the last quarter. Institutional investors own 64.52% of the company’s stock.
Analyst Ratings Changes
NTR has been the subject of a number of research analyst reports. Royal Bank of Canada reduced their price target on shares of Nutrien from $135.00 to $120.00 and set an “outperform” rating for the company in a research note on Monday, November 7th. Mizuho reduced their price target on shares of Nutrien from $93.00 to $91.00 and set a “neutral” rating for the company in a research note on Thursday, January 12th. TD Securities reduced their price target on shares of Nutrien from $105.00 to $91.00 and set a “buy” rating for the company in a research note on Sunday, November 6th. Credit Suisse Group set a $65.00 price target on shares of Nutrien and gave the stock an “underperform” rating in a research note on Monday, January 9th. Finally, Morgan Stanley reduced their price target on shares of Nutrien from $100.00 to $91.00 and set an “equal weight” rating for the company in a research note on Wednesday, January 11th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $100.06.
Nutrien Stock Up 1.5 %
Nutrien (NYSE:NTR – Get Rating) last issued its quarterly earnings results on Wednesday, November 2nd. The company reported $2.51 EPS for the quarter, missing the consensus estimate of $3.92 by ($1.41). The firm had revenue of $8.19 billion during the quarter, compared to analysts’ expectations of $9.02 billion. Nutrien had a net margin of 20.60% and a return on equity of 29.68%. As a group, research analysts expect that Nutrien Ltd. will post 13.55 earnings per share for the current year.
Nutrien Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 13th. Shareholders of record on Friday, December 30th were paid a $0.48 dividend. The ex-dividend date was Thursday, December 29th. This represents a $1.92 annualized dividend and a yield of 2.52%. Nutrien’s dividend payout ratio is presently 13.67%.
Nutrien Company Profile
Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia.
- Get a free copy of the StockNews.com research report on Nutrien (NTR)
- Does it Matter Folks Aren’t “Starry-Eyed” Over Pepsi’s New Soda?
- Can Alaska Air Continue Soaring Above The Airline Industry?
- Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
- Insulet Has Potential To Gain More Than Analysts Are Forecasting
- Cathie Wood Is Buying These Stocks, Should You?
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.